Clinical Study Results
Research Sponsor: AstraZeneca AB
Treatment Studied: Tezepelumab
Study Purpose: A study to find out about tezepelumab given through
2 different injection devices in participants with
severe asthma
Protocol Number: D5180C00011
Thank you!
Thank you for taking part in the clinical study for the study drug tezepelumab.
You and all of the participants and their caregivers helped researchers learn more about
tezepelumab to help people with severe asthma.
AstraZeneca AB sponsored this study and believes it is important to share the results of
the study with the participants, their caregivers, and the public. An independent non-profit
organization called CISCRP helped prepare this summary of the study results for you. We
hope it helps you understand and feel proud of your important role in medical research.
If you participated in the study and have questions about the results, please speak with the
study doctor or staff at your study site.